Decoding Causal Links Between Sleep Apnea and Alzheimer's Disease
Luigi Ferini-Strambi, Michael Hensley1, Maria Salsone2,3
1John Hunter Hospital and The University of Newcastle, Newcastle, Australia.
Journal of Alzheimer'S Disease : JAD
|January 18, 2021
Summary
Obstructive sleep apnea (OSA) and Alzheimer's disease (AD) share a causal link. This review explores how OSA affects brain regions vulnerable to AD neuropathology, proposing a new OSA-AD neurodegeneration model.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Obstructive sleep apnea (OSA) and Alzheimer's disease (AD) are prevalent chronic conditions with a known association.
- Emerging evidence suggests a potential causal neurobiological link between OSA and AD.
- Understanding this link is crucial for developing targeted interventions.
Purpose of the Study:
- To review brain regions and networks affected by OSA.
- To explore their vulnerability to AD neuropathology.
- To investigate gender-specific implications in the OSA-AD relationship.
Main Methods:
- Narrative review of existing literature.
- Neuroimaging studies analysis.
- Neuropathological investigations integration.
Main Results:
- Identification of specific brain regions and networks impacted by OSA.
- Evidence supporting these regions as vulnerable to AD pathology.
- Discussion of gender-related differences in OSA's impact on brain health.
Conclusions:
- A novel model, OSA-AD neurodegeneration, is proposed to explain the causal link.
- This model highlights shared neurodegenerative pathways.
- Further research is needed to validate the model and explore therapeutic strategies.
Related Concept Videos
Sleep Apnea
308
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
308
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Insufficient Sleep and Sleep Deprivation
649
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
649
Sleepwalking and Sleep Talking
488
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
488
Alzheimer's Disease: Treatment
586
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
586
Understanding Sleep
1.2K
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
1.2K


